4
$ABT · Abbott Laboratories
AI overview
A Form 4 filing from Abbott Laboratories reports a change in beneficial ownership by Mary K. Moreland, an executive vice president of the company. The filing states that on November 5, 2026, Moreland sold 3,500 common shares without par value at a price of $116 per share. Following that transaction, she directly held 100,791 common shares.
The filing also notes that Moreland indirectly held 17,345 common shares through the Abbott Laboratories Stock Retirement Trust as of November 5, 2026. No transactions in derivative securities were reported. The form was signed and filed on November 6, 2026.
Related & recent SEC filings